Navigation Links
Case Western Reserve geneticist receives prestigious NIH Director's Pioneer Award
Date:8/6/2010

Noted geneticist, Joseph Nadeau, PhD, of Case Western Reserve University School of Medicine, has received a 2010 National Institutes of Health (NIH) Director's Pioneer Award.

One of 17 awardees to receive this prestigious distinction, Dr. Nadeau will investigate transgenerational genetic effects, where the biological features and disease risk of an individual has been found to depend as much on the genetics of ancestral generations as on their own inherited genes. His discovery of this unexpected mode of inheritance challenges the most fundamental premise of most studies where an individual's genes, environmental exposures and life experiences are customarily thought to determine their health status.

"This NIH Director's Pioneer Award is a once-in-a-lifetime opportunity to study this new mode of inheritance" says Dr. Nadeau, the James H. Jewel Professor and Chair of Genetics Department. The five-year grant is supported by an award of $3.9 million.

An enormous international effort is currently underway to discover the genetic basis for common human diseases. While many important discoveries have been made, most of the genes have eluded discovery. As a result, the goal of diagnosing, treating and preventing common birth defects and adult diseases remains unfulfilled.

Discovery of transgenerational genetic effects helps reconcile the general sense that traits and diseases 'run' in families. That is, having a family member with a disease dramatically increases the inherited risk for everyone else in the family. Although familial occurrence remains the single strongest factor for disease risk, these genes have proven extraordinarily hard to find, a problem that has been called 'missing heritability'. If these genetic variants act across generations, as Dr. Nadeau's evidence suggests, then traits can still have a genetic basis, but the 'disease genes' may present themselves in previous generations and not necessarily in the affe
'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Pancreatic cancers use fructose, common in the Western diet, to fuel their growth
2. UT Southwestern researchers find key step in bodys ability to make red blood cells
3. Case Western Reserve awarded $4.7 million from Defense Advanced Research Projects Agency
4. UT Southwestern researchers use novel sperm stem-cell technique to produce genetically modified rats
5. Temperature and salt levels of the Western Mediterranean are on the increase
6. UT Southwestern researchers find mechanism that may stop E. coli from developing in cattle
7. UT Southwestern researchers identify key molecular step to fighting off viruses
8. Case Western Reserve team discovers smart insulin molecule
9. UT Southwesterns BioCenter driving biotech, medical innovation in North Texas
10. New brain nerve cells key to stress resilience, UT Southwestern researchers find
11. UT Southwestern student receives fellowship from Howard Hughes Medical Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... July 2, 2015 Fingerprint Cards has ... FPC1145 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... will be used by smartphone manufacturers in Asia ... in the communicated revenue guidance of approximately 2,200 MSEK for ...
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool ... toward a healthier, happier life. That,s exactly what USANA,s ... to do. The cutting-edge, portable health program provides a ... solutions to help improve your lifestyle and nutrition. ... dinner and gala Wednesday night, USANA,s THA was honored ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... T. Gonzalez-Bellido, who is now a postdoctoral scientist at ... Hughes Medical Institute, University of Minnesota, and Union College ... editorial board of Proceedings of the National Academy ... colleagues were honored for the "scientific excellence and originality" ...
... from the National Physical Laboratory (NPL) has shown that by ... almost halve its performance. According to the ... hence the heating bill) is lost through an un-insulated roof. ... save on energy bills but needs to be installed correctly ...
... New Zealand) and Erik van Nieukerken ( Naturalis Biodiversity Center , ... Greek mythology and the legendary Italian philanderer Giacomo Casanova in a ... study was published in the open access journal ZooKeys ... 8 millimetres, belong to a very old group (the family Nepticulidae), ...
Cached Biology News:Study of dragonfly prey detection wins PNAS Cozzarelli Prize 2Study of dragonfly prey detection wins PNAS Cozzarelli Prize 3Squashed loft insulation 50 percent less effective 2Tiny minotaurs and mini-Casanovas: Ancient pigmy moths reveal secrets of their diversity 2
(Date:7/28/2015)... ... ... Xsample 530 sample changer for vials can be used with Anton Paar density ... than 12,000 mPas (internal air) up to 36,000 (external air) – and can process up ... Xsample 530 is its removable magazine, which is easily lifted off its hub and carried ...
(Date:7/28/2015)... ... July 28, 2015 , ... In ... billion in 2013; while production volume reached close to 1.84 million tonnes in ... a share of 75.5% of the region’s total aluminium hydroxide production; the country’s ...
(Date:7/28/2015)... -- Deerfield Management Company, L.P. today announced the launch ... invest in groundbreaking advancements in science that may lead ... diseases. The venture capital fund will also back new ... improve the way healthcare is delivered to patients. ... funds in the sector, will donate all profits not ...
(Date:7/28/2015)... , July 28, 2015 BioStructures, ... it has hit a milestone of 4,000 implantations ... FDA 510(k) cleared in early 2014 as a ... posterolateral spine fusion procedures.  This is a distinguished ... less than 6% of new synthetic products have ...
Breaking Biology Technology:New Moves in Automatic Sample Handling: Introducing Xsample 530 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3Revolutionary Bone Graft Exceeds Expectations 2
... Pa., Sept. 7, 2011 Tengion, Inc (NASDAQ: ... Brian Davis, Vice President and Chief Financial Officer of Tengion, ... Healthcare Conference on Tuesday, September 13, 2011, at 1:35 pm ... can be accessed under "Calendar of Events" in the Investors ...
... 2011 The Journal of Cell Biology ... pleased to announce their next enhancement to the JCB ... published scientific image data. Starting today, data from genome-wide ... with papers published in JCB. HCS data are increasingly ...
... 7, 2011 Debiopharm Group™ ... focuses on serious medical conditions and particularly ... privately-held, biopharmaceutical company dedicated to the discovery ... cancer, have entered into an exclusive worldwide ...
Cached Biology Technology:Tengion to Present at Rodman & Renshaw 13th Annual Healthcare Conference 2Glencoe Software and The Journal of Cell Biology Pioneer Publishing of Genome-Wide Screens 2Glencoe Software and The Journal of Cell Biology Pioneer Publishing of Genome-Wide Screens 3Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T 2Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T 3